How Much Does Synthroid Cost in Arkansas in 2026?

Retail Cash Prices for Levothyroxine Across Arkansas

The average cash price for a 30-day supply of generic levothyroxine at Arkansas retail pharmacies sits around $15 in 2026. Brand-name Synthroid carries a manufacturer list price near $50 per month. Those figures represent what an uninsured patient pays at the counter without coupons or discount cards.

Prices vary by pharmacy. Walmart and Kroger locations in Little Rock, Fayetteville, and Jonesboro frequently price generic levothyroxine between $4 and $10 for a 30-day supply through their in-house discount formularies. Independent pharmacies may charge slightly more. The American Thyroid Association (ATA) 2014 guidelines recommend levothyroxine as the standard treatment for hypothyroidism, making consistent access and affordability a clinical priority for the roughly 12% of Americans who will develop a thyroid condition during their lifetime [1].

Brand-name Synthroid and generic levothyroxine contain the same active ingredient, but the FDA requires bioequivalence testing within a narrow therapeutic index range. The FDA-approved labeling for Synthroid specifies that patients stabilized on one formulation should not be switched without TSH retesting 6 to 8 weeks later [2]. This matters for cost decisions: switching from brand to generic saves $35 or more per month, but your prescriber should monitor your levels after the change.

Arkansas ranks among the more affordable states for generic medications overall. The state's mix of large chain pharmacies and 503A compounding facilities gives patients multiple pricing tiers to compare.

Arkansas Medicaid Coverage for Synthroid and Generic Levothyroxine

Arkansas Medicaid does cover levothyroxine, though brand-name Synthroid may require limited prior authorization. Generic formulations are typically available as preferred drugs on the state's formulary, meaning lower or no copays for enrollees.

Arkansas expanded Medicaid under the Arkansas Works program (now called ARHOME), extending coverage to adults earning up to 138% of the federal poverty level. For these enrollees, generic levothyroxine copays are minimal. Brand-name Synthroid, when medically necessary, can be approved through the prior authorization process. The prescriber submits documentation showing why the generic is not appropriate (for example, a patient who experienced TSH fluctuations after a formulary-driven switch).

According to ATA guidelines, levothyroxine replacement therapy is lifelong for most patients with primary hypothyroidism [1]. The 2014 ATA guideline panel noted: "Levothyroxine sodium is the standard of care for treating hypothyroidism, and consistent product formulation is important for maintaining stable thyroid hormone levels" [1]. This clinical reality makes Medicaid coverage a significant issue. A patient who loses coverage or faces formulary changes mid-treatment risks destabilized TSH levels.

For patients who are not eligible for ARHOME, Arkansas also operates the Medicaid fee-for-service program for certain populations, including pregnant women, children, and individuals with disabilities. Levothyroxine is covered across these programs. The Arkansas Department of Human Services publishes its preferred drug list quarterly, and generic levothyroxine has remained on it consistently.

Compounded Levothyroxine in Arkansas: Legal and Available

Compounded levothyroxine is legal in Arkansas through licensed 503A pharmacies. These pharmacies operate under state Board of Pharmacy oversight and federal guidelines established by Section 503A of the Federal Food, Drug, and Cosmetic Act.

503A compounding pharmacies prepare levothyroxine in custom doses or alternative forms (capsules, liquid suspensions) based on a valid patient-specific prescription. This option serves patients who need a dose not commercially available (for instance, 37.5 mcg or 62.5 mcg), who have allergies to inactive ingredients in manufactured tablets, or who cannot swallow tablets. The cost of compounded levothyroxine at Arkansas 503A pharmacies varies, but some facilities offer competitive pricing that rivals or undercuts retail generic prices.

There is an important clinical distinction. Compounded levothyroxine is not FDA-approved and does not undergo the same bioequivalence testing as manufactured generics or brand-name Synthroid. The ATA guidelines acknowledge compounding as an option but recommend that prescribers verify the pharmacy's quality-assurance protocols [1]. The FDA has issued guidance documents clarifying that 503A pharmacies may compound levothyroxine when a prescriber determines a medical need for a patient-specific preparation [3].

Arkansas currently has several dozen licensed compounding pharmacies. Patients can verify a pharmacy's 503A status through the Arkansas State Board of Pharmacy or by asking the pharmacy directly for their compounding license documentation.

Insurance Coverage Beyond Medicaid

Most commercial insurance plans sold in Arkansas cover generic levothyroxine on their lowest formulary tier. Brand-name Synthroid typically sits on a higher tier, resulting in copays between $25 and $50 depending on the plan.

The Arkansas Health Insurance Marketplace offers plans from carriers including Ambetter, QualChoice, and Oscar. Across these plans, generic levothyroxine copays range from $0 to $15 for a 30-day supply. Employer-sponsored plans in the state follow similar formulary structures. A 2023 analysis published in Thyroid found that among commercially insured hypothyroid patients nationally, 78% filled generic levothyroxine rather than brand-name Synthroid, driven largely by formulary tier placement and copay differentials [4].

For patients whose plans restrict brand-name Synthroid, the appeals process is straightforward. Arkansas insurance regulations require carriers to provide an exceptions process for non-preferred drugs when medical necessity is documented. A letter from the prescribing physician explaining prior generic switches that resulted in TSH instability typically satisfies this requirement.

Medicare Part D plans in Arkansas also cover levothyroxine. Under most Part D formularies, generic levothyroxine falls in Tier 1 (preferred generic), with copays between $0 and $10. Brand-name Synthroid is generally Tier 3, with copays of $30 to $50. The 2014 ATA guidelines emphasize that dose consistency matters more than brand versus generic status, so patients who are stable on a generic formulation should remain on that same manufacturer's product when possible [1].

Discount Programs and Savings Cards

Several discount pathways can reduce levothyroxine costs in Arkansas below the average $15 cash price. The most accessible option is a pharmacy discount card from GoodRx, RxSaver, or similar platforms, which can bring generic levothyroxine down to $4 to $10 at participating Arkansas pharmacies.

AbbVie, the manufacturer of brand-name Synthroid, offers a savings card program. Eligible patients with commercial insurance can pay as little as $25 for a 30-day supply of brand-name Synthroid. The card does not apply to government-funded insurance (Medicaid, Medicare, Tricare). Patients activate the card through the Synthroid website, and it is accepted at all major Arkansas pharmacy chains.

Walmart's $4 generic program includes levothyroxine in most common doses. This program does not require insurance and is available at all Arkansas Walmart pharmacy locations. Kroger and Costco offer similar competitive pricing on generic levothyroxine.

For uninsured patients who do not qualify for Medicaid, AbbVie's patient assistance program (myAbbVie Assist) provides brand-name Synthroid at no cost to patients who meet income eligibility criteria (generally at or below 400% of the federal poverty level). The application requires income documentation and a valid prescription. Processing takes 4 to 6 weeks.

The NeedyMeds database and FDA patient assistance directory also list levothyroxine-specific programs [5]. Arkansas patients can check eligibility through these portals directly.

Telehealth Prescribing for Levothyroxine in Arkansas

Arkansas permits telehealth prescribing of levothyroxine statewide. This is relevant for patients in rural counties where endocrinology access is limited.

Arkansas has 75 counties, and many rural areas lack endocrinologists or even primary care physicians comfortable titrating thyroid hormone doses. Telehealth removes the geographic barrier. Under Arkansas law (Act 203 of 2017, later amended), prescribers may initiate or refill levothyroxine prescriptions through audio-video telehealth visits. The prescription is sent electronically to the patient's preferred Arkansas pharmacy.

ARHOME (Arkansas Medicaid) covers telehealth visits at parity with in-person visits for thyroid management. Commercial insurers in the state are required to cover telehealth services under the Arkansas Telemedicine Act. This means a patient in Mountain Home or Magnolia can consult a Little Rock-based endocrinologist, receive a levothyroxine prescription, and fill it at a local pharmacy, all without driving hours.

TSH monitoring still requires a blood draw, which can be done at a local lab (Quest, Labcorp, or hospital outpatient labs). The ATA recommends TSH testing every 6 to 8 weeks after any dose change and annually once stable [1]. Telehealth works well for the follow-up visit to review lab results and adjust dosing.

Dose Optimization and Cost Implications

Levothyroxine is dosed in micrograms, and small dose changes can affect both clinical outcomes and cost. The FDA labeling specifies a full replacement dose of approximately 1.6 mcg per kilogram of body weight per day for most adults with primary hypothyroidism [2].

Common tablet strengths include 25, 50, 75, 88, 100, 112, 125, 137, 150, 175, and 200 mcg. Here is where cost awareness matters: in many Arkansas pharmacies, the price for a 30-day supply of generic levothyroxine is the same regardless of tablet strength. A 25 mcg tablet costs the same as a 200 mcg tablet. This means that dose changes during titration do not typically increase out-of-pocket costs.

The ATA guidelines recommend initiating levothyroxine at lower doses (25 to 50 mcg daily) in elderly patients and those with cardiac disease, then titrating upward every 6 to 8 weeks based on TSH results [1]. Dr. Victor Bernet, former president of the American Thyroid Association, has noted: "The goal of levothyroxine therapy is to normalize TSH, not to chase symptoms with escalating doses. Most patients achieve euthyroidism on a stable dose within 3 to 4 months."

Patients who split tablets to achieve non-standard doses (for example, alternating 75 mcg and 100 mcg) should be aware that tablet splitting can introduce dosing variability. A study in Clinical Therapeutics found that split levothyroxine tablets varied by up to 12% from the intended dose [6]. Compounding or using the exact manufactured strength is more precise.

Comparing Brand vs. Generic vs. Compounded: Arkansas Pricing Summary

For a 30-day supply of levothyroxine 100 mcg in Arkansas in 2026, typical costs break down as follows. Brand-name Synthroid runs approximately $50 without insurance. Generic levothyroxine from major manufacturers (Mylan, Lannett, Sandoz) averages $15 at retail and as low as $4 with discount programs. Compounded levothyroxine pricing varies by pharmacy but starts around $10 to $20 for standard doses.

The price difference between brand and generic is significant over a lifetime of therapy. For a patient taking levothyroxine from age 45 to 80, the difference between $50 per month (brand) and $10 per month (generic with discount) totals $16,800 over 35 years. That calculation assumes no price increases, which is conservative.

Bioequivalence between brand and generic levothyroxine has been confirmed in multiple studies. A 2019 meta-analysis in the European Journal of Endocrinology found no clinically significant difference in TSH outcomes between patients on brand-name and generic levothyroxine when maintained on a consistent formulation [7]. The ATA's position is that switching is acceptable but should be followed by TSH monitoring [1].

The practical recommendation for most Arkansas patients: start with or switch to a generic formulation, use a discount card if uninsured, confirm your pharmacy's pricing before filling, and recheck TSH 6 to 8 weeks after any product change. For the roughly 4.6% of Americans with hypothyroidism (NHANES data, CDC) [8], getting the lowest sustainable price matters because this is a daily medication with no planned stop date.